GlassScriptPhysician profile
David Sosnoski
NPI 1114542776
$27,908.79
in general payments reported to CMS, 2019-2025
11 companies · $23K in 2025
The $23K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,984 · 2022: $683 · 2023: $1,952 · 2024: $580 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $2,638 · Food and Beverage: $1,939 · Education: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $2,638.33 |
| Food and Beverage | $1,939.08 |
| Education | $664.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,839.36 | 2025 | |
| Pinnacle, INC | $1,293.05 | 2021-2024 | |
| Medical Device Business Services, INC. | $1,264.93 | 2021-2025 | Actis |
| Encore Medical, LP | $1,171.02 | 2023-2024 | Djo Surgical |
| Stryker Corporation | $970.71 | 2021-2025 | Pangea, Variax, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $670.14 | 2021-2025 | Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $458.57 | 2021-2024 | Na, Inhance, Tfn-Advance |
| Heron Therapeutics, INC. | $111.50 | 2024 | Zynrelef |
| Elevate Surgical Co | $79.41 | 2025 | |
| Conformis, INC. | $46.05 | 2021 | |
| My01 INC. | $4.05 | 2023 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sosnoski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.